Cannabinoid prodrug compounds

A compound represented by Formula I,

• wherein:
• X is
• wherein:
• R1 is selected from the group consisting of H, C1-10 alkyl, C1-4 alkyl-aryl, C1-4 alkyl-heteroaryl;
• R2 is H or C1-10 alkyl optionally substituted with OH, SH, SC1-4 alkyl, heteroaryl, CONH2, COOH, NH2, NHC(NH)NH2, or aryl, wherein the heteroaryl and aryl is optionally substituted with CN, halogen, CF3, C1-4 alkyl or OH;
• and R3 is selected from the group consisting of C1-10 alkyl, C1-4 alkyl-aryl, C1-4 alkyl-heteroaryl, and
• wherein
• Ra in each instance is OH, or OC1-10alkyl, provided that Ra is a covalent bond when Ra is in a non-terminal position;
• Rb in each instance is independently H or C1-10 alkyl optionally substituted with OH, SH, SC1-4 alkyl, heteroaryl, CONH2, COOH, NH2, NHC(NH)NH2, or aryl, wherein the heteroaryl and aryl is optionally substituted with CN, halogen, CF3, C1-4 alkyl or OH;
• Rc in each instance is independently selected from the group consisting of H, C1-10 alkyl, C1-4 alkyl-aryl, C1-4 alkyl-heteroaryl, wherein Rb and Rc optionally link up to form a 5 to 7 membered ring;
• and m is an integer ranging from 1 to 9.